DCM
QCOR

Dialectic Capital Management’s QUESTCOR PHARMA INC QCOR Stock Holding History

Dialectic Capital Management’s Portfolio QCOR Stock Details QCOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-200,851
Closed -$9.13M – 256
2013
Q2 		$9.13M Buy
+200,851
New +$7.13M 1.33% 15

Other funds holding QCOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dialectic Capital Management's QCOR Position: Q3 2013 in Review

Dialectic Capital Management sold out of QUESTCOR PHARMA INC (QCOR) in Q3 2013, closing a stake of 200,851 shares — an estimated $9.13M sold.

Dialectic Capital Management first reported a position in QCOR in Q2 2013 and held it in 1 quarter. The position peaked at $9.13M in Q2 2013. 284 funds tracked by Wall St. Rank hold QCOR as of Q3 2013.

  • Dialectic Capital Management reported no remaining QUESTCOR PHARMA INC position as of Q3 2013 after selling out during the quarter.
  • Dialectic Capital Management sold 200,851 QUESTCOR PHARMA INC shares in Q3 2013, an estimated $9.13M.
  • Dialectic Capital Management first reported a position in QUESTCOR PHARMA INC in Q2 2013 and held it in 1 quarter.
  • Dialectic Capital Management's QUESTCOR PHARMA INC position peaked at $9.13M in Q2 2013.
  • 284 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q3 2013.

Based on Dialectic Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.